YWYumei Wang

Yumei Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yumei Wang has a total of 75 co-authors. Here are the top co-authors by number of shared publications:

  • Lin Lu

    Institute of Mental Health, Key Laboratory of Mental Health and Peking University Sixth Hospital, National Clinical Research Center for Mental Disorders, Peking University, Beijing, China

    3 shared publications
  • Nobuhiko Hoaki

    Oita Univ, Fac Med, Dept Neuropsychiat, Hasamamachi, Yufu 8795593, Japan

    3 shared publications
  • Tianle Zhang

    Department of Psychiatry, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

    3 shared publications
  • Tingting Xie

    Institute of Brain Science and Brain-Inspired Research, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shangdong, China

    3 shared publications
  • Xiaobo Wang

    Department of Psychiatry, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

    3 shared publications
  • Fangming Xu

    Department of Psychiatry, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

    2 shared publications

Latest Publications

  • Open Access

    The alteration of IL-17 signaling pathway in bipolar disorder: a preliminary study with transcriptomic perspective

    by Xiaobo Wang, Su Yu, Zhen Gao, Fangming Xu, Yumei Wang, Tianle Zhang, Tingting Xie, Xihua Jia

    Objective: Bipolar Disorder (BD) is a complex psychiatric condition influenced by genetic and environmental factors. This study aims to explore global mRNA expression in Peripheral blood white cells (PBMC) of BD patients.Methods: We analyzed whole-genome gene expression profiles from PBMC of 12 BD states-manic (BD-M), 12 BD states-depressive (BD-D), and 12 matched healthy controls (HC) using microarrays. Validation of differentially expressed genes within the IL-17 pathway was conducted through qRT-PCR, while ELISA measured specific protein levels. GO and KEGG pathway enrichment analyses were performed, alongside PPI analysis and Gene Set Variation Analysis (GSVA) to assess immune cell infiltration.Results: In the comparison between BD and HC, a total of 304 differentially expressed genes (DEGs) were identified, of which 217 genes were upregulated and 87 genes were downregulated. In the comparisons between BD and HC, BD-M and HC, and BD-D and HC, 91 DEGs were found. Enrichment analysis suggested that biological processes and signaling pathways related to extracellular matrix, stress response, heparin binding, and immune inflammation were upregulated in the BD group. KEGG analysis and PPI results indicate that the IL-17 signaling pathway plays an important role in BD and its subtypes. In the IL-17 signaling pathway, compared to HC, the expression of Jun, Fosb, Fosl1, TNFAIP3, NFKBIA, CXCL2, CXCL8, IL6 and IL17 genes was upregulated in BD patients. RT-qPCR analysis showed that the expression of Jun, Fosb, Fosl1, NFKBIA, TNFAIP3, CXCL2, and CXCL8 genes was significantly upregulated in BD, ELISA results indicated that the protein levels of CXCL8/IL-8, IL-6 and IL-17 in the BD group were significantly higher than those in the HC group (all P < 0.05). Immune infiltration analysis showed that central memory CD4+ T cells (P=0.010), eosinophils (P=0.038), and mast cells (P=0.029) were increased in infiltration in the BD group.Conclusion: This study integrates transcriptomics and immune microenvironment analysis, suggesting that the IL-17 signaling pathway may be involved in the pathogenesis of BD and its subtypes through inflammation triggered by chemokines. This research deepens our understanding of the molecular mechanisms of BD and emphasizes the importance of the immune system in its pathology.


  • Top Cited Papers
    Open Access

    Practical AI application in psychiatry: historical review and future directions

    by Jie Sun, Tangsheng Lu, Xuexiao Shao, Ying Han, Yu Xia, Yongbo Zheng, Yongxiang Wang, Xinmin Li, Arun Ravindran, Lizhou Fan, et al.

    The integration of artificial intelligence (AI) in mental healthcare holds promise for enhancing diagnostic precision, treatment efficacy, and personalized care. Despite AI’s potential to analyze vast datasets and identify subtle patterns, its clinical adoption in psychiatry remains limited. This review critically examines the emerging role of AI in psychiatry, elucidating its utility, challenges, and implications for clinical practice. Through an extensive analysis of the existing literature and empirical evidence, we seek to inform psychiatric stakeholders about both opportunities and obstacles that are presented by AI. We evaluate AI’s potential to improve diagnostic accuracy, prognostic performance, and therapeutic interventions. Our pragmatic approach bridges the gap between theoretical advancements and practical implementation, providing valuable insights and actionable recommendations for psychiatric professionals. This article highlights the supportive role of AI, advocating for its judicious integration to enhance patient outcomes while maintaining the human-centric essence of psychiatric practice. By addressing these challenges and fostering collaboration, AI can significantly advance mental healthcare, reduce clinical burdens, and improve patient outcomes.


  • To nap or not? Evidence from a meta-analysis of cohort studies of habitual daytime napping and health outcomes

    by Ying-Bo Yang, Yong-Bo Zheng, Jie Sun, Lu-Lu Yang, Jiao Li, Yi-Miao Gong, Ming-Zhe Li, Xin Wen, Hao-Yun Zhao, Pei-Pei Shi, et al.


  • Open Access

    Analysis of complete blood count and derived inflammatory indicators for bipolar disorder patients with different states

    by Fangming Xu, Xiaobo Wang, Tianle Zhang, Tingting Xie, Xiao Xin, Yaxuan Zhao, Yumei Wang

    Purposes: This study aimed to analyze the predictive ability of the complete blood count and derived inflammatory indicators for BD patients with different states to identify potential biomarkers.Methods: We collected the data of BD in-patients from January 2021 to March 2023. The complete blood count and derived inflammatory indicators were computed by univariate analysis, logistic regression analysis, and receiver operating characteristic (ROC) curve analysis.Results: In terms of BD patients, the levels of MON (pp = 0.018), and NLR (p = 0.002) were independent risk factors in logistic regression analysis, as well as the cut-off values were 0.405 109/L, 2.600 mg/L, and 2.321, respectively. Regarding BD-M patients, the levels of MON (pp = 0.012), and NLR (p = 0.002) were predictors in logistic regression analysis, and the cut-off values were, respectively, 0.505 109/L, 2.600 mg/L, and 2.620. Additionally, the levels of NLR (p = 0.006) and MHR (pp = 0.001) was related to BD-mixed and the cut-off value was 0.340 109/L. Notably, MON+hs-CRP + NLR, MON+hs-CRP + NLR, and NLR + MHR had the highest diagnostic accuracy to predict BD, BD-M, and BD-D patients, respectively.Conclusion: Our findings showed that distinct inflammatory indicators were closely associated with BD and its different states. Additionally, we also identified their cut-off values and optimal combined predictive indicators in different states of BD, helping us improve diagnostic accuracy and better assess them to manage early targeted interventions.


  • Open Access

    Perinatal exposure to earthquake stress increases the risks of hypertension and diabetes in subsequent adult life: A cross‐sectional study

    by Na Li, Lu‐Lu Yu, Xiao‐Chuan Zhao, Mei Song, Lan Wang, Yuan‐Yuan Gao, Wen‐Ting Lu, Xue‐Yi Wang, Yu‐Mei Wang

    The objective of the current study was to determine whether exposure to earthquake stress during pregnancy and infancy impacted on the risk of chronic adult health problems. All subjects were divided into three groups: the infant exposure group, the fetus exposure group, and the non‐exposure group. All subjects completed a standardized interview that included questions on demographic information, traumatic experiences during the earthquake, Anthropomorphic parameters such as body height, weight, and blood pressure were measured. Traumatic events in childhood and adulthood were assessed by the Childhood Trauma Questionnaire (CTQ) and Life Event Scale (LES), respectively. Totally1325 subjects were included; 399 subjects experienced the earthquake as fetuses, 374 subjects who experienced the earthquake as infants and 552 subjects did not experience the earthquake. The three groups were comparable in sociodemographic and baseline characteristics except age (Infant exposure vs Prenatal exposure vs No exposure = 39.5 ± 0.6 vs 38.5 ± 0.8 vs 37.5 ± 0.9, p < .001). Fetal and infant exposure to earthquakes was associated with elevated systolic blood pressure (both were + 3 mm Hg, p < .001). After adjustment for covariates, earthquake exposure in infants (odds ratio [OR] = 2.010, 95% confidence interval [CI] = 1.216 ~ 3.322) and fetuses (OR = 1.509, 95% CI = 1.014 ~ 2.248) was a significant and independent risk factor for hypertension. Earthquake expose in fetuses was a significant and independent risk factor for diabetes (OR = 2.307, 95% CI = 1.136 ~ 4.686). Earthquake exposure in infants and fetuses is a significant and independent risk factor for hypertension. Earthquake exposure in fetuses is significant and independent risk factor for diabetes.


  • Prevalence of insomnia and its risk factors in older individuals: a community-based study in four cities of Hebei Province, China

    by Yu-Mei Wang, Hong-Guang Chen, Mei Song, Shun-Jiang Xu, Lu-Lu Yu, Lan Wang, Ran Wang, Le Shi, Jia He, Yue-Qin Huang, et al.


  • Type A behavior pattern: Bortner scale vs. Japanese-original questionnaires

    by Yumei Wang, Takeshi Terao, Nobuhiko Hoaki, Shinjiro Goto, Yasuo Araki, Kentaro Kohno, Yoshinori Mizokami


    • 1 January 2010
      • Vol. 112  (3) , 274-9

    [Reconsideration of bipolar disorder and lithium therapy].

    by Takeshi Terao, Shinjiro Goto, Nobuhiko Hoaki, Yumei Wang

  • Open Access

    Pharmacotherapy for visual hallucinations:

    by Takatoshi Hikichi, Takeshi Terao, Kensuke Kodama, Shinjiro Goto, Nobuhiko Hoaki, Yumei Wang